The risks of different FDA-approved or FDA-authorized vaccines after a booster dose are similar to those experienced after a primary series, which includes Discuss the risks and benefits and which product may be most appropriate with individual patients.Ĭlinical trial data using homologous or heterologous (“mix and match”) boosters show that both increase immune response. For groups recommended to receive a booster, people have the option to receive any of the FDA-approved or FDA-authorized COVID-19 booster products (Pfizer-BioNTech, Moderna or Janssen).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |